Company
South Korean biopharmaceutical contract development and manufacturing (CDMO) company based in Songdo, Incheon; a Samsung Group affiliate listed on KRX (207940).
South Korea lost 489,190 working days to strikes through September, 24.2% more than in all of last year, labor ministry data show. The losses trace to disputes at large workplaces, so a few big employers' wage talks now set the national figure.
Reality
Samsung Biologics' union asked Samsung Electronics, its roughly 31% shareholder, to bargain over pay and promotions as its employer. The claim tests how far Korea's Yellow Envelope law reaches into a corporate group, while a three-week strike from Oct. 26 could cost, at May's loss rate, about a quarter's operating profit.
Reality
Korea's SME ministry broke ground on a 217.3 billion won lab hub in Songdo built to house 60 bio startups by 2028. Private money is 8.1 billion won of that, so the state is building the cluster before investors have shown they will follow the tenants in.
Reality
Core CPI at 0.3% for August pushed futures to 86% from 69% on a September Fed hike, and Seoul's open took SK hynix down 5.24% to 1.717 million won. Philadelphia's semiconductor index had closed 1.81% higher on the 11th.
Reality
Samsung Biologics is paying for peptide capacity with new stock rather than debt, and the arithmetic inside its own 15.4 trillion won decade plan says the antibody campus, not GLP-1, still gets most of the money.
Reality